Levtam 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication primarily indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit abnormal neuronal firing and reduce seizure activity. This medication is typically prescribed as adjunctive therapy but may also be used as monotherapy depending on clinical judgment. Levtam 500 is well-absorbed orally, with rapid onset of action and minimal drug interactions, making it suitable for patients requiring long-term seizure control. The dosage should be individualized based on patient response, renal function, and tolerability, with gradual titration recommended to minimize adverse effects. Common side effects include dizziness, somnolence, headache, and fatigue, while serious adverse reactions such as behavioral changes or hypersensitivity are rare but require prompt medical attention. Levtam 500 should be used cautiously in patients with renal impairment and monitored regularly to ensure therapeutic efficacy and safety. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any of its excipients.